I strongly support efforts to extend this exemption period from 9 years to 13, ensuring parity between small molecules and biologics.
Ron Wyden: “I strongly support efforts to extend this exemption period from 9 years to 13, ensuring parity between small molecules…”
On the recordMarch 21, 2023
Source
congress.govEditor's note · Context
Wyden advocates for extending the exemption period for drug pricing to support innovation.
Share
More from Ron Wyden
Oct 2, 2026
The proposed rule is clear regulatory overreach that would have disastrous impacts for lawfully present immigrants and their families who are legally eligible for refundable tax credits.
Oct 8, 2026
This interpretation is wildly inconsistent with the longstanding treatment of other provisions that use identical or near-identical language.
Oct 8, 2026
This throws doubt upon Treasury’s interpretation of many provisions of the Code, creates a great deal of uncertainty in the administration of our tax laws, and could balloon the deficit.





